Suchergebnisse - "Warimwe, George M"

PubPharm (83)

1

SARS-CoV-2 Seroprevalence in three Kenyan Health and Demographic Surveillance Sites, December 2020-May 2021

enthalten in: bioRxiv.org | 2024

von Etyang, A. | Adetifa, I. | Omore, R. | +39

2

SARS-CoV-2 seroprevalence and implications for population immunity : Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022

enthalten in: Influenza and other respiratory viruses | 2023

von Kagucia, E. | Ziraba, A. | Nyagwange, J. | +35

3

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE) : a randomised, double-blind, non-inferiority substudy of a phase 4 trial

enthalten in: The Lancet. Infectious diseases | 2023

von Kimathi, D. | Juan-Giner, A. | Orindi, B. | +23

CommentIn: Lancet Infect Dis. 2023 Aug;23(8):889-890. - PMID 37127046

4

Temporal trends of dengue seroprevalence among children in coastal Kenya, 1998–2018: a longitudinal cohort study

enthalten in: bioRxiv.org | 2023

von Karanja, H. | Orindi, B. | Gitonga, J. | +11

5

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults : an open-label, non-randomised, first-in-human phase 1 clinical trial

enthalten in: The Lancet. Infectious diseases | 2023

von Jenkin, D. | Wright, D. | Folegatti, P. | +16

CommentIn: Lancet Infect Dis. 2023 Aug;23(8):887-889. - PMID 37060918

6

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE) : a randomised, double-blind, non-inferiority substudy of a phase 4 trial

enthalten in: The Lancet. Infectious diseases | 2023

von Juan-Giner, A. | Namulwana, M. | Kimathi, D. | +16

CommentIn: Lancet Infect Dis. 2023 Aug;23(8):889-890. - PMID 37127046

7

A Customizable Suite of Methods to Sequence and Annotate Cattle Antibodies

enthalten in: Vaccines | 2023

von Ramirez Valdez, K. | Nzau, B. | Dorey-Robinson, D. | +11

8

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Nyagwange, J. | Kutima, B. | Mwai, K. | +17

9

COVID-19 Transmission Dynamics Underlying Epidemic Waves in Kenya

enthalten in: bioRxiv.org | 2022

von Brand, S. | Ojal, J. | Aziza, R. | +30

10

Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya

enthalten in: bioRxiv.org | 2022

von Kagucia, E. | Gitonga, J. | Kalu, C. | +61

1
2
3
4
5
6
7
8
9
Nächster »
[9]